Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
methylprednisolone acetate + isopropyl alcohol + povidone-iodine + lidocaine
- Development stage
- Unknown
- Lead developer
- Asclemed USA
- Modality
- Small Molecules
- Administration
- Intramuscular, Intraarticular, Intralesional, Parenteral
01
Overview
Dyural L Kit is a multi-component injectable kit containing **methylprednisolone acetate, isopropyl alcohol, povidone-iodine, and lidocaine**. The therapeutic component is methylprednisolone acetate, a depot synthetic glucocorticoid corticosteroid that binds the glucocorticoid receptor and suppresses inflammatory and immune signaling, while lidocaine provides local anesthetic effect and isopropyl alcohol plus povidone-iodine function as antiseptic preparation components. The product has been described as a single-dose 40 mg/mL methylprednisolone acetate injectable suspension intended for intramuscular, intra-articular, soft tissue, or intralesional administration in inflammatory, allergic, rheumatologic, dermatologic, hematologic, endocrine, and other steroid-responsive disorders. Publicly provided context identifies Asclemed USA as the developer of this kit, and the labeling context states that the product has not been found by the FDA to be safe and effective and its labeling has not been approved by the FDA.
- Brand names
- Dyural L Kit
- Other names
- methylprednisolone acetate + isopropyl alcohol + povidone-iodine + lidocaine
02
Targets
NaV (Voltage-gated sodium channels)TRPC5 (Transient receptor potential Canonical-5)GR (Glucocorticoid receptor)
Beyond the preview
Go deeper on methylprednisolone acetate + isopropyl alcohol + povidone-iodine + lidocaine.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on methylprednisolone acetate + isopropyl alcohol + povidone-iodine + lidocaine.